The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation.

Zoltan CziganyWiebke KrampIsabella LurjeHannah MillerJan BednarschSven Arke LangTom Florian UlmerPhilipp BrunersPavel StrnadChristian TrautweinMartin Wolfgang von WebskyFrank TackeUlf Peter NeumannGeorg Lurje

Published in: Journal of cachexia, sarcopenia and muscle (2021)

Preoperative myosteatosis may be an important prognostic marker in patients undergoing deceased donor liver transplantation. The prognostic value of myosteatosis seems to be particularly important in the early post-operative phase. Validation in prospective clinical trials is warranted.

Keyphrases

patients undergoing
clinical trial
kidney transplantation
case report
randomized controlled trial
open label
double blind